Rchr

J-GLOBAL ID：201301068734680537 Update date: Mar. 05, 2023

Kawano Yasumasa

カワノヤスマサ | Kawano Yasumasa

Affiliation and department：
Papers (23)：

KAWANO Yasumasa, MARUYAMA Junichi, HOKAMA Ryo, KOIE Megumi, NAGASHIMA Ryotaro, HOSHINO Kota, MURANISHI Kentaro, NAKASHIO Maiko, NISHIDA Takeshi, Ishikura Hiroyasu. Outcomes in patients with infections and augmented renal clearance: A multicenter retrospective study. PLOS ONE. 2018
SATO Eiichi, TOGAWA Atsushi, MASAKI Michio, SHIRAHASHI Akihiko, KUMAGAWA Midori, KAWANO Yasumasa, Ishikura Hiroyasu, YAMASHIRO Yuri, TAKAGI Satoshi, TO Hiromi, et al. Community-acquired Disseminated Exophiala dermatitidis Mycosis with Necrotizing Fasciitis in Chronic Graft-versus-host Disease. Internal Medicine Advanced Publication. 2018
Hoshino K, Muranishi K, Kawano Y, Hatomoto H, Yamasaki S, Nakamura Y, Ishikura H. Soluble fibrin is a useful marker for predicting extracorporeal membrane oxygenation circuit exchange because of circuit clots. J Artif Organs. 2018. 21. 2. 196-200
Kota Hoshino, Taisuke Kitamura, Yoshihiko Nakamura, Yuhei Irie, Norihiko Matsumoto, Yasumasa Kawano, Hiroyasu Ishikura. Usefulness of plasminogen activator inhibitor-1 as a predictive marker of mortality in sepsis. Journal of Intensive Care. 2017. 5. 1. 42
Yasumasa Kawano, Atsushi Togawa, Yoshihiko Nakamura, Mariko Mizunuma, Reiko Yamasaki, Kota Hoshino, Takeshi Nishida, Hiroyasu Ishikura. Prognostic factors for candidaemia in intensive care unit patients: a retrospective analysis. SINGAPORE MEDICAL JOURNAL. 2017. 58. 4. 196-200

ｍore...

Lectures and oral presentations (22)：

敗血症診療における医者の思考回路
(平成30年度日臨技九州支部医学検査学会(第53回) 2018)
「救命救急センターの取り組み」 2.Respiratory ECMO(重症呼吸不全患者への対応)
(第9回糸島医師会・福大病院地域連携学術講演会 2018)
重症呼吸不全に対するawake ECMOの功罪
(第33回日本救命k両学会総会・学術集会 2018)
Augmented Renal Clearance(ARC)の発症予測にeGFRは有用か
(第44回日本集中治療医学会 2017)
敗血症の新定義に基づいたバイオマーカーの有用性の検討
(第21回エンドトキシン血症救命治療研究会 2017)

ｍore...

Professional career (1)：

学士(医学)

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page

TOP

BOTTOM